Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

US Patent 12016856 · Granted Jun 25, 2024

Estimated economic value: $26,595,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Glycyrrhetinic acid derivatives for use in treating hyperkalemia2024
Compounds and methods for inhibiting phosphate transport2023
Compounds and methods for inhibiting phosphate transport2023
Compounds and methods for inhibiting phosphate transport2023
Glycyrrhetinic acid derivatives for treating hyperkalemia2023
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2022
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2022
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2022
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2022